Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IMUX similar filings
- 10 Aug 20 Entry into a Material Definitive Agreement
- 3 Aug 20 Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis
- 27 Jul 20 Regulation FD Disclosure
- 7 Jul 20 Submission of Matters to a Vote of Security Holders
- 19 Jun 20 Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19
- 12 Jun 20 Immunic, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
- 19 May 20 Other Events
Filing view
External links